The Goldman Sachs Group, Inc. 13D and 13G filings for Biotech Acquisition Company:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 10:50 am Sale |
2022-12-30 | 13G | Biotech Acquisition Company BIOT |
GOLDMAN SACHS GROUP INC GS |
250,525 1.100% |
-944,153 (-79.03%) |
Filing |
| 2023-02-13 5:21 pm Purchase |
2022-12-30 | 13G | Biotech Acquisition Company BIOT |
GOLDMAN SACHS GROUP INC GS |
250,525 1.100% |
250,525 (New Position) |
Filing |
| 2022-02-10 12:29 pm Purchase |
2021-12-31 | 13G | Biotech Acquisition Company BIOT |
GOLDMAN SACHS GROUP INC GS |
1,194,678 5.200% |
1,194,678 (New Position) |
Filing |